Simplex Trading, LLC Sangamo Therapeutics, Inc Transaction History

Simplex Trading, LLC

  • $195 Billion
  • Q3 2025

A detailed history of Simplex Trading, LLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Simplex Trading, LLC holds 9,609 shares of SGMO stock, worth $4,227. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,609
Previous 125,333 92.33%
Holding current value
$4,227
Previous $67,000 91.04%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
SELL
$0.44 - $0.7 $50,918 - $81,006
-115,724 Reduced 92.33%
9,609 $6,000
Q2 2025

Aug 05, 2025
SELL
$0.43 - $0.81 $50,293 - $94,738
-116,961 Reduced 48.27%
125,333 $67,000
Q1 2025

May 12, 2025
BUY
$0.66 - $1.37 $32,838 - $68,165
49,756 Added 25.84%
242,294 $158,000
Q4 2024

Feb 11, 2025
BUY
$0.78 - $2.87 $60,685 - $223,291
77,802 Added 67.81%
192,538 $196,000
Q3 2024

Nov 08, 2024
BUY
$0.32 - $1.1 $22,666 - $77,915
70,832 Added 161.33%
114,736 $98,000
Q2 2024

Jul 25, 2024
BUY
$0.36 - $0.65 $356 - $642
989 Added 2.3%
43,904 $15,000
Q1 2024

Apr 25, 2024
BUY
$0.42 - $1.38 $5,012 - $16,468
11,934 Added 38.52%
42,915 $28,000
Q4 2023

Feb 02, 2024
SELL
$0.3 - $0.63 $2,551 - $5,357
-8,504 Reduced 21.54%
30,981 $16,000
Q3 2023

Nov 01, 2023
SELL
$0.58 - $1.47 $6,928 - $17,559
-11,945 Reduced 23.23%
39,485 $23,000
Q2 2023

Aug 04, 2023
BUY
$1.11 - $1.74 $26,782 - $41,982
24,128 Added 88.37%
51,430 $66,000
Q1 2023

Apr 27, 2023
BUY
$1.66 - $3.67 $27,773 - $61,402
16,731 Added 158.27%
27,302 $48,000
Q4 2022

Feb 02, 2023
SELL
$2.77 - $5.07 $47,674 - $87,259
-17,211 Reduced 61.95%
10,571 $33,000
Q3 2022

Nov 04, 2022
BUY
$4.27 - $6.39 $67,414 - $100,885
15,788 Added 131.63%
27,782 $136,000
Q2 2022

Aug 03, 2022
SELL
$3.28 - $6.21 $100,190 - $189,690
-30,546 Reduced 71.81%
11,994 $49,000
Q1 2022

May 02, 2022
SELL
$5.23 - $7.82 $52,362 - $78,293
-10,012 Reduced 19.05%
42,540 $247,000
Q4 2021

Feb 23, 2022
BUY
$7.29 - $10.97 $213,290 - $320,960
29,258 Added 125.6%
52,552 $394,000
Q3 2021

Oct 28, 2021
BUY
$9.01 - $12.01 $2,703 - $3,603
300 Added 1.3%
23,294 $279,000
Q2 2021

Aug 12, 2021
BUY
$10.17 - $12.64 $83,882 - $104,254
8,248 Added 55.93%
22,994 $275,000
Q1 2021

Apr 26, 2021
SELL
$10.88 - $17.05 $501,198 - $785,425
-46,066 Reduced 75.75%
14,746 $0
Q4 2020

Feb 02, 2021
BUY
$9.23 - $18.18 $292,037 - $575,215
31,640 Added 108.46%
60,812 $948,000
Q3 2020

Oct 14, 2020
SELL
$9.38 - $12.48 $328,937 - $437,648
-35,068 Reduced 54.59%
29,172 $275,000
Q2 2020

Jul 13, 2020
BUY
$6.21 - $11.83 $251,865 - $479,801
40,558 Added 171.26%
64,240 $575,000
Q1 2020

Apr 29, 2020
SELL
$5.05 - $8.85 $156,777 - $274,748
-31,045 Reduced 56.73%
23,682 $150,000
Q4 2019

Feb 05, 2020
BUY
$8.03 - $11.7 $27,607 - $40,224
3,438 Added 6.7%
54,727 $458,000
Q3 2019

Oct 15, 2019
BUY
$9.05 - $12.22 $5,701 - $7,698
630 Added 1.24%
51,289 $464,000
Q2 2019

Jul 26, 2019
BUY
$8.75 - $13.03 $360,578 - $536,953
41,209 Added 436.07%
50,659 $545,000
Q1 2019

Apr 18, 2019
SELL
$7.72 - $12.81 $237,235 - $393,651
-30,730 Reduced 76.48%
9,450 $0
Q4 2018

Jan 16, 2019
BUY
$9.51 - $16.6 $220,822 - $385,452
23,220 Added 136.91%
40,180 $461,000
Q3 2018

Oct 23, 2018
SELL
$13.05 - $19.05 $440,868 - $643,566
-33,783 Reduced 66.58%
16,960 $287,000
Q2 2018

Jul 30, 2018
BUY
$13.9 - $19.8 $4,767 - $6,791
343 Added 0.68%
50,743 $720,000
Q1 2018

Apr 26, 2018
BUY
$16.7 - $26.35 $841,680 - $1.33 Million
50,400 New
50,400 $957,000

Others Institutions Holding SGMO

# of Institutions
124
Shares Held
62.5M
Call Options Held
953K
Put Options Held
1.11M
View Full List

About SANGAMO THERAPEUTICS, INC

SGMO Quotes by TradingView
  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $68.9M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email